UC joins clinical trial to test treatment for abdominal injury
February 16, 2024
Researchers at the University of Cincinnati are part of a clinical study for ResQFoam, a new device for the treatment of life-threatening abdominal internal bleeding. UC Medical Center is one of a handful of Level I Trauma Centers in the United States selected to participate in the multicenter Reducing Exsanguination Via In‐Vivo Expandable Foam (REVIVE) study.